Guardant Health, Inc. is a precision oncology company that provides blood and tissue tests, datasets, and analyzes in the United States and internationally. The company offers Guardant360. Guardant360 LDT; Guardant360 CDx Test. Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect is an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with practical modifications to can be linked to certain clinical studies. GuardantOMNI test for advanced stage cancer. GuardantINFORM is an in silico research platform on tumor evolution and treatment resistance in cancer based on various biomarkers. Provides a shield test. Guardant Reveal Test for selecting adjuvant therapy in patients with early stage cancer. Smart Liquid Biopsy Platform; Guardant Galaxy is an AI-assisted digital pathology platform that helps improve cancer biomarker detection. Additionally, the company provides development services such as companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, test development and support, technology licensing, and kit fulfillment. The company has a collaborative agreement with Illumina, Inc. to share specimen samples to advance cancer research. The company was founded in 2011 and is headquartered in Palo Alto, California.
guardanthealth.com
Source link
